Title: Cost analysis of three-dimensional radiation therapy versus intensity- modulated chemoradiotherapy for locally advanced cervical cancer in Peruvian citizens
Authors: José Fernando Robles Díaz
Section: Conflicts of interest declaration
Phys 89(2) 260–267 https://doi.org/10.1016/j.ijrobp.2014.02.018 PMID: 24721589 47. Bacorro W, Baldivia K, and Dumago M, et al (2022) Phase 1/2 trial evaluating the effectiveness and safety of dose-adapted hypofractionated pelvic radiotherapy for advanced cervical cancers INeligible for chemotherapy (HYACINCT) Acta Oncol 61(6) 688–697 https:// doi.org/10.1080/0284186X.2022.2048070 PMID: 35285405 48. Ministerio de Salud (MINSA) (2020) Análisis de la situación del Cáncer en el Perú, 2018 [Internet] (Lima: MINSA) http://bvs.minsa.gob.pe/ local/MINSA/5158.pdf Date accessed: 19/01/23 49. Ndlovu N (2019) Radiotherapy treatment in cancer control and its important role in Africa Ecancermedicalscience13 942 https://doi. org/10.3332/ecancer.2019.942 PMID: 31552115 PMCID: 6722105 50. Datta NR, Samiei M, and Bodis S (2014) Radiation therapy infrastructure and human resources in low- and middle-income countries: present status and projections for 2020 Int J Radiat Oncol Biol Phys 89(3) 448–457 https://doi.org/10.1016/j.ijrobp.2014.03.002 PMID: 24751411 51. Datta NR, Rogers S, and Bodis S (2019) Challenges and opportunities to realize “The 2030 agenda for sustainable development” by the United Nations: implications for radiation therapy infrastructure in low- and middle-income countries Int J Radiat Oncol Biol Phys 105(5) 918–933 https://doi.org/10.1016/j.ijrobp.2019.04.033 PMID: 31451317 52. Atun R, Jaffray DA, and Barton MB, et al (2015) Expanding global access to radiotherapy Lancet Oncol 16(10) 1153–1186 https://doi. org/10.1016/S1470-2045(15)00222-3 PMID: 26419354 53. Apás Pérez De Nucci A, Minig L, and Perrotta M (2017) Patterns of cervical cancer care in Argentina: applying ASCO recommendations adjusted by local resources Gynecol Oncol Rep 21 61–66 https://doi.org/10.1016/j.gore.2017.06.012 PMID: 28702501 PMCID: 5496480 54. Hanly P, Céilleachair AÓ, and Skally M, et al (2015) Direct costs of radiotherapy for rectal cancer: a microcosting study BMC Health Serv Res 15 184 https://doi.org/10.1186/s12913-015-0845-9 PMID: 25934169 PMCID: 4494796 55. Li C, Chen J, and Zhu J, et al (2019) Plan quality comparison for cervical carcinoma treated with Halcyon and Trilogy intensity-modulated radiotherapy J Cancer 10(24) 6135–6141 https://doi.org/10.7150/jca.32500 PMID: 31762823 PMCID: 6856582 56. Pawlicki T, Atwood T, and McConnell K, et al (2019) Clinical safety assessment of the Halcyon system Med Phys 46(10) 4340–4345 https://doi.org/10.1002/mp.13736 PMID: 31350914 57. Healy BJ, van der Merwe D, and Christaki KE, et al (2017) Cobalt-60 machines and medical linear accelerators: competing technologies for external beam radiotherapy Clin Oncol (R Coll Radiol) 29(2) 110–115 https://doi.org/10.1016/j.clon.2016.11.002 58. Cetnar AJ and DiCostanzo DJ (2021) The lifetime of a linac monitor unit ion chamber J Appl Clin Med Phys 22(12) 108–114 https://doi. org/10.1002/acm2.13463 PMID: 34762336 PMCID: 8664141